Edgemoor Investment Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $328K | Sell |
2,727
-60
| -2% | -$6.93K | 0.03% | 136 |
|
|
2025
Q4 | $293K | Sell |
2,787
-1,831
| -40% | -$172K | 0.02% | 144 |
|
|
2025
Q3 | $388K | Sell |
4,618
-39,189
| -89% | -$3.23M | 0.03% | 137 |
|
|
2025
Q2 | $3.47M | Sell |
43,807
-2,858
| -6% | -$227K | 0.3% | 58 |
|
|
2025
Q1 | $4.19M | Sell |
46,665
-2,268
| -5% | -$212K | 0.39% | 53 |
|
|
2024
Q4 | $4.87M | Sell |
48,933
-1,635
| -3% | -$169K | 0.43% | 48 |
|
|
2024
Q3 | $5.74M | Sell |
50,568
-902
| -2% | -$107K | 0.5% | 47 |
|
|
2024
Q2 | $6.37M | Sell |
51,470
-693
| -1% | -$89.3K | 0.59% | 42 |
|
|
2024
Q1 | $6.88M | Sell |
52,163
-1,852
| -3% | -$228K | 0.65% | 39 |
|
|
2023
Q4 | $5.89M | Sell |
54,015
-732
| -1% | -$76K | 0.62% | 40 |
|
|
2023
Q3 | $5.64M | Sell |
54,747
-2,025
| -4% | -$218K | 0.67% | 39 |
|
|
2023
Q2 | $6.55M | Sell |
56,772
-180
| -0.3% | -$20.4K | 0.74% | 39 |
|
|
2023
Q1 | $6.06M | Sell |
56,952
-3,906
| -6% | -$422K | 0.74% | 41 |
|
|
2022
Q4 | $6.75M | Buy |
60,858
+1,551
| +3% | +$159K | 0.85% | 38 |
|
|
2022
Q3 | $5.11M | Sell |
59,307
-65
| -0.1% | -$5.8K | 0.68% | 43 |
|
|
2022
Q2 | $5.41M | Sell |
59,372
-1,215
| -2% | -$108K | 0.68% | 42 |
|
|
2022
Q1 | $4.97M | Buy |
60,587
+296
| +0.5% | +$23.3K | 0.52% | 50 |
|
|
2021
Q4 | $4.62M | Sell |
60,291
-18,340
| -23% | -$1.46M | 0.47% | 51 |
|
|
2021
Q3 | $5.91M | Sell |
78,631
-32,039
| -29% | -$2.44M | 0.67% | 46 |
|
|
2021
Q2 | $8.61M | Sell |
110,670
-970
| -0.9% | -$72.1K | 0.8% | 42 |
|
|
2021
Q1 | $8.21M | Buy |
111,640
+30,028
| +37% | +$2.21M | 0.82% | 43 |
|
|
2020
Q4 | $6.37M | Buy |
81,612
+44,024
| +117% | +$3.37M | 0.71% | 44 |
|
|
2020
Q3 | $2.98M | Buy |
+37,588
| New | +$2.94M | 0.37% | 54 |
|
|
2019
Q1 | – | Sell |
-12,476
| Closed | -$910K | – | 140 |
|
|
2018
Q4 | $910K | Sell |
12,476
-96,563
| -89% | -$6.82M | 0.14% | 79 |
|
|
2018
Q3 | $7.38M | Sell |
109,039
-1,569
| -1% | -$100K | 0.92% | 41 |
|
|
2018
Q2 | $6.41M | Sell |
110,608
-7,386
| -6% | -$417K | 0.86% | 43 |
|
|
2018
Q1 | $6.13M | Sell |
117,994
-12,729
| -10% | -$687K | 0.82% | 45 |
|
|
2017
Q4 | $7.74M | Sell |
130,723
-18,109
| -12% | -$1M | 0.98% | 40 |
|
|
2017
Q3 | $9.09M | Sell |
148,832
-3,652
| -2% | -$221K | 1.23% | 31 |
|
|
2017
Q2 | $9.32M | Sell |
152,484
-1,161
| -0.8% | -$70.7K | 1.27% | 31 |
|
|
2017
Q1 | $9.31M | Sell |
153,645
-886
| -0.6% | -$53.8K | 1.32% | 33 |
|
|
2016
Q4 | $8.68M | Buy |
154,531
+5,926
| +4% | +$347K | 1.32% | 32 |
|
|
2016
Q3 | $8.85M | Buy |
148,605
+42,747
| +40% | +$2.5M | 1.36% | 29 |
|
|
2016
Q2 | $5.82M | Buy |
105,858
+33,309
| +46% | +$1.77M | 0.92% | 44 |
|
|
2016
Q1 | $3.66M | Buy |
72,549
+68,460
| +1,674% | +$3.35M | 0.57% | 60 |
|
|
2015
Q4 | $206K | Sell |
4,089
-604
| -13% | -$30.5K | 0.03% | 133 |
|
|
2015
Q3 | $221K | Hold |
4,693
| – | – | 0.03% | 132 |
|
|
2015
Q2 | $255K | Hold |
4,693
| – | – | 0.04% | 123 |
|
|
2015
Q1 | $257K | Hold |
4,693
| – | – | 0.04% | 119 |
|
|
2014
Q4 | $254K | Sell |
4,693
-25
| -0.5% | -$1.39K | 0.04% | 122 |
|
|
2014
Q3 | $267K | Buy |
4,718
+803
| +21% | +$45.1K | 0.04% | 120 |
|
|
2014
Q2 | $216K | Sell |
3,915
-361
| -8% | -$19.7K | 0.03% | 129 |
|
|
2014
Q1 | $232K | Hold |
4,276
| – | – | 0.04% | 119 |
|
|
2013
Q4 | $204K | Buy |
+4,276
| New | +$195K | 0.03% | 126 |
|
Other funds holding MRK
VCM
VPM
Edgemoor Investment Advisors's MRK Position: Q1 2026 in Review
Edgemoor Investment Advisors reduced its Merck (MRK) stake by 2.2% in Q1 2026, selling an estimated $6.93K and leaving 2,727 shares worth $328K. The position accounts for 0.03% of the portfolio, ranked #136.
Edgemoor Investment Advisors first reported a position in MRK in Q4 2013 and has held it in 44 quarters since. The position peaked at $9.32M in Q2 2017. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Edgemoor Investment Advisors held 2,727 shares of Merck worth $328K as of Q1 2026.
- Edgemoor Investment Advisors sold 60 Merck shares in Q1 2026, an estimated $6.93K.
- Merck made up 0.03% of Edgemoor Investment Advisors's portfolio in Q1 2026, its #136 holding.
- Edgemoor Investment Advisors first reported a position in Merck in Q4 2013 and has held it in 44 quarters since.
- Edgemoor Investment Advisors's Merck position peaked at $9.32M in Q2 2017.
- 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Edgemoor Investment Advisors's 13F filing for Q1 2026, filed 13 May 2026.